David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
CALL
Tyson Foods
TSN
$19.9B
| $1.05M | ﹤0.01% |
11,500
+100
| +0.9% | +$8.6K |
|
|
EGIO
2902
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.04M | ﹤0.01% |
6,406
+4,480
| +233% | +$709K |
|
2903
SAP
SAP
$244B
| $1.04M | ﹤0.01% |
7,795
-342
| -4% | -$44.9K |
|
|
VISN
2904
PUT
Vistance Networks Inc
VISN
$2.55B
| $1.04M | ﹤0.01% |
73,500
| – | – |
|
|
CLVS
2905
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.04M | ﹤0.01% |
100,000
+30,000
| +43% | +$218K |
|
|
CLVS
2906
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.04M | ﹤0.01% |
100,000
| – | – |
|
|
CONN
2907
DELISTED
Conn's Inc.
CONN
| $1.04M | ﹤0.01% |
84,039
-21,558
| -20% | -$452K |
|
|
K
2908
DELISTED
Kellanova
K
| $1.04M | ﹤0.01% |
+16,008
| New | +$970K |
|
|
ZAYO
2909
CALL
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $1.04M | ﹤0.01% |
30,000
-50,000
| -63% | -$1.71M |
|
|
BBBY
2910
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.04M | ﹤0.01% |
60,000
| – | – |
|
2911
AppFolio
APPF
$7.9B
| $1.04M | ﹤0.01% |
9,428
+2,693
| +40% | +$275K |
|
2912
PUT
Theravance Biopharma
TBPH
$884M
| $1.04M | ﹤0.01% |
40,000
-500
| -1% | -$9.72K |
|
2913
CALL
Axsome Therapeutics
AXSM
$10.9B
| $1.03M | ﹤0.01% |
+10,000
| New | +$404K |
|
2914
Avis
CAR
$5.09B
| $1.03M | ﹤0.01% |
31,967
+19,607
| +159% | +$588K |
|
2915
QCR Holdings
QCRH
$1.65B
| $1.03M | ﹤0.01% |
23,452
-10,542
| -31% | -$431K |
|
2916
Trustmark
TRMK
$2.69B
| $1.03M | ﹤0.01% |
29,808
-13,988
| -32% | -$483K |
|
2917
PUT
AudioCodes
AUDC
$242M
| $1.03M | ﹤0.01% |
+40,000
| New | +$875K |
|
2918
CALL
Diageo
DEO
$52.1B
| $1.03M | ﹤0.01% |
6,100
-13,400
| -69% | -$2.18M |
|
2919
Accenture
ACN
$111B
| $1.03M | ﹤0.01% |
4,874
-2,127
| -30% | -$415K |
|
2920
Johnson Outdoors
JOUT
$477M
| $1.03M | ﹤0.01% |
13,376
+3,438
| +35% | +$225K |
|
|
DLPH
2921
PUT
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $1.03M | ﹤0.01% |
80,000
-26,500
| -25% | -$343K |
|
2922
PUT
Baker Hughes
BKR
$61.5B
| $1.02M | ﹤0.01% |
40,000
| – | – |
|
2923
J&J Snack Foods
JJSF
$1.66B
| $1.02M | ﹤0.01% |
5,557
-21,577
| -80% | -$4.06M |
|
2924
Tilray
TLRY
$638M
| $1.02M | ﹤0.01% |
5,969
+4,600
| +336% | +$951K |
|
2925
CALL
Gen Digital
GEN
$17.7B
| $1.02M | ﹤0.01% |
+40,000
| New | +$977K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.